Molecular Landscape of Pediatric Low-Grade Gliomas: Insights From RNA-NGS and Bioinformatic Analysis.
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F25%3AN0000018" target="_blank" >RIV/27283933:_____/25:N0000018 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/00216208:11130/25:10503930 RIV/00064203:_____/25:10503930
Výsledek na webu
<a href="https://onlinelibrary.wiley.com/doi/epdf/10.1002/gcc.70085" target="_blank" >https://onlinelibrary.wiley.com/doi/epdf/10.1002/gcc.70085</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/gcc.70085" target="_blank" >10.1002/gcc.70085</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Molecular Landscape of Pediatric Low-Grade Gliomas: Insights From RNA-NGS and Bioinformatic Analysis.
Popis výsledku v původním jazyce
Pediatric low-grade gliomas (pLGG) are the most common group of childhood brain tumors. Genetic alterations in the RAS–RAF–mitogen-activated protein kinase (MAPK) pathway are the molecular drivers in the vast majority of pLGG. A large pro-portion of pediatric pLGG are characterized by the presence of fusion genes. An institutional molecular analysis together withan RNA-NGS study was performed to reveal LGG-associated molecular alterations. In our cohort of pLGG patients, molecularalterations were identified in 318 out of 342 cases (92.9%) through a combination of RT-PCR, Sanger sequencing, and NGS meth-odologies. Fusion events were independently called using three fusion callers: Archer Analysis 6.0 and/or 7.0, Arriba version 2.4,and STAR-Fusion 24. Among these, STAR-Fusion had the lowest sensitivity, detecting rearrangements in only 67% of fusion-positive cases. In contrast, Arriba detected rearrangements in 97.77% of cases, while Archer detected rearrangements in 88.6%of cases. These findings highlight differences in detection efficiency among fusion callers, emphasizing the importance of toolselection in molecular diagnostics. The detection of fusion genes is very important for correct diagnosis, prognosis, and adequatetargeted treatment.
Název v anglickém jazyce
Molecular Landscape of Pediatric Low-Grade Gliomas: Insights From RNA-NGS and Bioinformatic Analysis.
Popis výsledku anglicky
Pediatric low-grade gliomas (pLGG) are the most common group of childhood brain tumors. Genetic alterations in the RAS–RAF–mitogen-activated protein kinase (MAPK) pathway are the molecular drivers in the vast majority of pLGG. A large pro-portion of pediatric pLGG are characterized by the presence of fusion genes. An institutional molecular analysis together withan RNA-NGS study was performed to reveal LGG-associated molecular alterations. In our cohort of pLGG patients, molecularalterations were identified in 318 out of 342 cases (92.9%) through a combination of RT-PCR, Sanger sequencing, and NGS meth-odologies. Fusion events were independently called using three fusion callers: Archer Analysis 6.0 and/or 7.0, Arriba version 2.4,and STAR-Fusion 24. Among these, STAR-Fusion had the lowest sensitivity, detecting rearrangements in only 67% of fusion-positive cases. In contrast, Arriba detected rearrangements in 97.77% of cases, while Archer detected rearrangements in 88.6%of cases. These findings highlight differences in detection efficiency among fusion callers, emphasizing the importance of toolselection in molecular diagnostics. The detection of fusion genes is very important for correct diagnosis, prognosis, and adequatetargeted treatment.
Klasifikace
Druh
J<sub>ost</sub> - Ostatní články v recenzovaných periodicích
CEP obor
—
OECD FORD obor
30101 - Human genetics
Návaznosti výsledku
Projekt
<a href="/cs/project/LX22NPO5102" target="_blank" >LX22NPO5102: Národní ústav pro výzkum rakoviny</a><br>
Návaznosti
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Genes, Chromosomes and Cancer
ISSN
1045-2257
e-ISSN
1098-2264
Svazek periodika
64
Číslo periodika v rámci svazku
10
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
12
Strana od-do
—
Kód UT WoS článku
001591880100001
EID výsledku v databázi Scopus
2-s2.0-105018398794